Last data update: 15 January 2021 04:14 CET
Plasmid name: pLenti6-hRIPK4-VSV-puro (LMBP 10185)
|Price category:||Cat. 1 (cf. price list)|
|Status:||GeneCorner non-core plasmid|
|Cloned DNA:||Human receptor-interacting serine-threonine kinase 4 cDNA (RIPK4, RIP4, ANKRD3, ANKK2, DIK, PKK)
Vesicular stomatitis virus glycoprotein (VSV-G) epitope; C-terminal
|Promoter:||Rous sarcoma virus/human immunodeficiency virus hybrid long terminal repeat (RSV/HIV-1 5' LTR)
Human cytomegalovirus immediate early promoter (CMV-IE) and enhancer
Simian virus 40 early promoter (SV40 early)
Escherichia coli lac operon promoter
Phage T3 promoter
Phage T7 gene 10 promoter (T7g10)
|Terminator:||Rous sarcoma virus/human immunodeficiency virus hybrid long terminal repeat (RSV/HIV-1 3' LTR); modified HIV-1 3' LTR with deleted U3 region (ΔU3/3' LTR)
Simian virus 40 polyadenylation signal (SV40 polyA)
|Selection marker:||Ampicillin (amp)
|Replicon:||Escherichia coli plasmid pMB1 origin
Phage f1 origin
Simian virus 40 bidirectional origin (SV40)
|Host range:||Escherichia coli
Mammalian cells; SV40 permissive cells
|Parental clone:||pLenti6-VSV puro|
|Further information:||This Gateway expression plasmid was constructed by cloning the human RIPK4 coding sequence into the pLenti6-VSV puro vector via Gateway recombination.
The region from the HIV-1 Rev response element to the attB1 site, the N-terminal fragment of the human RIPK4 coding sequence and the region from the VSV epitope up to and including the puromycin resistance gene have been sequenced at GeneCorner.
Because the risk for recombination after each subcultivation is high, this plasmid is only available under the format of isolated plasmid DNA.
The nucleotide sequence of the human RIPK4 coding sequence corresponds with the EMBL Nucleotide Sequence Database accession number BC110618.1.
Other name of the plasmid is pLenti6puroVSV_hRIPK4 wt.
|EMBL Accession number:||BC110618.1, view at EMBL, GenBank, DDBJ|
|Latest sequence update:||01/12/2016|
|Authenticity test:||Restriction enzyme pattern analysed at GeneCorner: AgeI/SpeI, HindIII, NdeI and PvuII.|
|History of deposit:||The plasmid was deposited by Prof. Dr W. Declercq(1)(2). It was constructed by Dr C. Rösselet(1)(2).
(1) Inflammation Research Center, VIB, Ghent, Belgium
(2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
|Plasmid reference:||PhD thesis Corinne Urwyler
|Restricted distribution:||- BCCM MTA|
|Distributed as:||plasmid DNA|
|Host for distribution:||Escherichia coli K12 DH5α|
|Host reference:||Focus 8 (1986), 9
|Related host reference:||Grant et al., Proc. Natl. Acad. Sci. U.S.A. 87 (1990), 4645-4649 [PMID: 2162051]
Hanahan, in 'DNA Cloning: A Practical Approach Volume I', IRL Press, Oxford (1985), 109-135 [ISSN/ISBN: 0947946187]
Hanahan, J. Mol. Biol. 166 (1983), 557-580 [PMID: 6345791]
Rodriguez-Quinones et al., Focus 15 (1993), 110-112
Woodcock et al., Nucleic Acids Res. 17 (1989), 3469-3478 [PMID: 2657660]
|Cultivation medium:||LB-Lennox + ampicillin (100 μg/ml)|
|Biosafety level:||L1 in E. coli; L2 in mammalian cells|
|Other culture collection numbers:||-|
Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.